• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Ophthalmic Drugs Market size, share, growth, Trends Analysis Report, Industry Darwinism with Competitive Landscape, worldwide Forecast- 2023| At A CAGR 6.0%

September 26th, 2019 Market Research Future Releases

Latest Research Report By Market Research Future (MRFR)Ophthalmic Drugs Market Research Report: By Indication (Glaucoma, Retinal Disorder, Others), Class (Antiallergy, Anti-Inflammatory, And Others), Dosage (Eye Drops, Others), Product (Prescription, OTC Drug), Distribution Channel – Global Forecast Till 2023

The Central Players Featured In The Ophthalmic Drugs Market Are: Allergan Plc,Bausch & Lomb Inc.,Genentech Inc.,Merck & Co. Inc.,Pfizer Inc.,Actavis Generics,Regeneron Pharmaceuticals Inc.,Shire Plc,Sun Pharmaceutical Industries Limited,Santen Pharmaceutical Co. Ltd.,Teva Pharmaceutical Industries Ltd.,Valeant Pharmaceuticals International,and others

Market Highlights

It Is Estimated That The Ophthalmic Drugs Market Is Expected To Grow At A CAGR 6.0% During The Forecast Period Of 2017 To 2023.

Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In the recent years, various new and existing marketers have come up with effective drugs. For instance, in November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.

A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are a few factors propelling the growth of the global ophthalmic drugs market. According to the 2017 statistics suggested by the World Health Organization (WHO), the chronic eye disease is the main cause of vision loss, globally.

However, the high cost associated with a diagnosis of eye diseases, side effects of available treatment options, and lack of healthcare insurance may hamper the growth of the market.

The changes in lifestyle and environment have raised the incidence of eye disorders that require medicines to treat the situation. Reports that gauge the medical device industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects

The influence of factors such as increasing awareness of eye disease and increased research funding in ophthalmology is expected to motivate the ophthalmic drugs market in the coming years. The increased level of research into drugs for ophthalmic application is greatly inspiring the market for ophthalmic drugs in the forecast period. Moreover, the increased aging population is predicted to create additional opportunities for development in the approaching period.

Fill Out Details To Receive FREE Sample Here: https://www.marketresearchfuture.com/sample_request/5753

Industry Updates

February 2019- Bausch + Lomb, a leading eye health company, announced that it had received FDA approval for LOTEMAX SM (loteprednol etabonate ophthalmic gel). The new gel formulation is intended to treat postoperative inflammation and pain following ocular surgery.

Segmental Analysis

The segmentation of the ophthalmic drugs market is carried out on the basis of drug class, product, indication, type of dosage, and distribution channel. Based on indication, the ophthalmic drugs market is segmented into retinal disorders, inflammation/infection, glaucoma, dry eye, uveitis, allergies, and others. The segmentation of the market for ophthalmic drugs based on drug class comprises of antiglaucoma, anti-inflammatory, antiallergy, anti-VEGF agents, and others.

The anti-inflammatory segment is additionally segmented into steroidal drugs and nonsteroidal drugs. Based on the dosage, the ophthalmic drugs market is segmented into ointments, eye drops, capsules and tablets, eye solutions, and gels. By product, the ophthalmic drugs market is segmented into OTC drugs and prescription drugs. Based on the distribution channel, the ophthalmic drugs market is segmented into online pharmacies, drug stores, hospital pharmacies, and others.

Detailed Regional Analysis     

The examination of the regions in the ophthalmic drug market consists of regions such as the Middle East, Africa, Europe, America, and the Asia Pacific. The Americas region controls the ophthalmic drugs market due to the incidence of the patient population, intensifying prevalence of eye diseases, sophisticated technology, soaring healthcare expenditure, and the existence of the leading companies.

The European region controls the next position in the ophthalmic drugs market. It is anticipated that the government backing towards research and development spending, growing competition among marketers, and adjustments in reimbursement policies in healthcare are expected to guide the European market in the coming years.

The Asia Pacific region is the quickest mounting ophthalmic drugs market due to the presence of an enormous patient pool, growing demand, and expansion of healthcare technology globally. Moreover, the Middle East and Africa region control the minimum share of the ophthalmic drugs market owing to low growth, deficiency of technical knowledge, and deprived medical facilities.

Competitive Analysis

The progress of the market is expected to capture increased momentum in the coming years primarily due to the presence of conducive government policies. The growth turnaround in the market is expected to activate new opportunities for expansion of the market. The improvements in various domestic economies are expected to motivate the development of the market in the upcoming period. The accessibility to key tactical opportunities leading to consequent stabilization of inflation is anticipated to create promising openings for expansion in the coming years.

In the coming years, the influence exerted by relatively high-income levels in nations around the world and the potential gains observed to some of the currencies in the world is expected to reinforce the evolution of the market in the forecast period. A considerable rise in the number of investors in the market is projected to create an advantageous scenario for the progress of the market in the forecast period.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Ophthalmic Drugs Market, By Treatment

6.1 Introduction

6.2 Drug Class

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Devices

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Others

6.4.1 Market Estimates & Forecast, 2017–2023

Chapter 7. Global Ophthalmic Drugs Market, By End-User

7.1 Introduction

7.2 Hospitals

7.2.1 Market Estimates & Forecast, 2017–2023

7.3 Clinics

7.3.1 Market Estimates & Forecast, 2017–2023

7.4 Diagnostic Centers

7.4.1 Market Estimates & Forecast, 2017–2023

7.5 Drug Stores

7.5.1 Market Estimates & Forecast, 2017–2023

7.6 Pharmacies

7.6.1 Market Estimates & Forecast, 2017–2023

7.7 Others

7.7.1 Market Estimates & Forecast, 2017–2023

Chapter 8. Global Ophthalmic Drugs Market, By Region

Chapter 9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

9.3.1 Key Developments

Chapter 10 Company Profiles

10.1 Actavis Generics

10.1.1 Company Overview

10.1.2 Types Overview

10.1.3 Financials

10.1.4 SWOT Analysis

10.2 Allergan Plc

10.2.1 Company Overview

10.2.2 Types Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis Others……….

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs Of The Market

11.2 Key Companies To Watch

11.3 Prediction Of The Ophthalmic Drugs Industry

Chapter 12 Appendix

LIST OF TABLES

Table 1 Ophthalmic Drugs Industry Synopsis, 2017–2023

Table 2 Ophthalmic Drugs Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Ophthalmic Drugs Market, By Region, 2017–2023, (USD Million)

Table 4 Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)

Table 5 Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)

Table 6 Ophthalmic Drugs Market, By Type Of Dosage, 2017–2023, (USD Million)

Table 7 Ophthalmic Drugs Market, By Product, 2017–2023, (USD Million)

Table 8 Ophthalmic Drugs Market, By Distribution Channel, 2017–2023, (USD Million)

Table 9 North America Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)

Table 10 North America Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)

Table 11 North America Ophthalmic Drugs Market, By Type Of Dosage, 2017–2023, (USD Million)

Table 12 North America Ophthalmic Drugs Market, By Product, 2017–2023, (USD Million)

Table 13 North America Ophthalmic Drugs Market, By Distribution Channel, 2017–2023, (USD Million)

Table 14 U.S. Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)

Table 15 U.S. Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Ophthalmic Drugs Market

Figure 3 Segmentation Market Dynamics For Ophthalmic Drugs Market

Figure 4 Global Ophthalmic Drugs Market Share, By Indication 2016

Figure 5 Global Ophthalmic Drugs Market Share, By Drug Class 2016

Figure 6 Global Ophthalmic Drugs Market Share, By Type Of Dosage 2016

Figure 7 Global Ophthalmic Drugs Market Share, By Product 2016

Figure 8 Global Ophthalmic Drugs Market Share, By Distribution Channel 2016

Figure 9 North America Ophthalmic Drugs Market Share, By Country, 2016

Figure 10 Europe Ophthalmic Drugs Market Share, By Country, 2016

Figure 11 Asia Pacific Ophthalmic Drugs Market Share, By Country, 2016

Figure 12 Middle East & Africa Ophthalmic Drugs Market Share, By Country, 2016

Figure 13 Global Ophthalmic Drugs Market: Company Share Analysis, 2016 (%)

Figure 14 Actavis Generics: Key Financials

Figure 15 Actavis Generics: Segmental Revenue

Continued…

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.  MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email